SCHEMBL4409944

SCHEMBL4409944

CCC(=O)CC(=O)CCc1ccc(O)cc1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2RL1 P55085 1/20 0.56
IAPP P10997 2/20 0.54
TRPV1 Q8NER1 2/20 0.51
HDAC2 Q92769 1/20 0.50
HDAC8 Q9BY41 1/20 0.50
ALOX5 P09917 1/20 0.49
OR51E2 Q9H255 1/20 0.49
KDM4E B2RXH2 3/20 0.49
F13A1 P00488 1/20 0.49
BACE1 P56817 1/20 0.47
ESR1 P03372 4/20 0.46
ESR2 Q92731 1/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
CYP19A1 P11511 2/20 0.46
ALDH1A1 P00352 2/20 0.46
LMNA P02545 2/20 0.46
TP53 P04637 2/20 0.46
CYP3A4 P08684 2/20 0.46
HSD17B10 Q99714 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL107381 0.90 IAPP (0.65) F2RL1IAPPTRPV1HDAC2HDAC8
Letestuianin C SCHEMBL4410123 0.90 F2RL1 (0.60) F2RL1TRPV1HDAC2HDAC8ALOX5
SCHEMBL1645396 0.83 KDM4E (0.55) F2RL1TRPV1HDAC2HDAC8ALOX5
SCHEMBL13311578 0.83 TRPV1 (0.64) F2RL1TRPV1HDAC2HDAC8CYP19A1
SCHEMBL8108885 0.82 ESR1 (0.62) F2RL1IAPPTRPV1HDAC2HDAC8
SCHEMBL2862583 0.81 MMP12 (0.68) F2RL1TRPV1HDAC2HDAC8KDM4E
SCHEMBL1053043 0.81 IAPP (0.66) F2RL1IAPPTRPV1HDAC2HDAC8
SCHEMBL28349297 0.81 IAPP (0.84) IAPPTRPV1ALOX5OR51E2KDM4E
SCHEMBL31322120 0.80 F2RL1 (0.64) F2RL1TRPV1HDAC2HDAC8ALOX5
SCHEMBL3754312 0.80 CYP4F2 (0.57) F2RL1TRPV1HDAC2HDAC8ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105073757-B Dyeing process using a hair-dyeing precursor obtained from an iridoid, composition, precursor and device comprising such a precursor 莱雅公司 2019-12-17 CN disclosed
US-20090318565-A1 Novel Compositions for the Enhancement of the Anti-oxidant Potential of Hydrogenated Curcuminoids or Combinations Thereof MAJEED MUHAMMED 2009-12-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090318565-A1 Novel Compositions for the Enhancement of the Anti-oxidant Potential of Hydrogenated Curcuminoids or Combinations Thereof GPX4, HMOX1, GPX1 F2RL1 4334/4885IAPP 2035/4885TRPV1 2279/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.